KR100941174B1 - Furan derivatives, and process for preparing them using Ag catalyst - Google Patents

Furan derivatives, and process for preparing them using Ag catalyst Download PDF

Info

Publication number
KR100941174B1
KR100941174B1 KR1020070128539A KR20070128539A KR100941174B1 KR 100941174 B1 KR100941174 B1 KR 100941174B1 KR 1020070128539 A KR1020070128539 A KR 1020070128539A KR 20070128539 A KR20070128539 A KR 20070128539A KR 100941174 B1 KR100941174 B1 KR 100941174B1
Authority
KR
South Korea
Prior art keywords
group
mmol
solvent
diol
formula
Prior art date
Application number
KR1020070128539A
Other languages
Korean (ko)
Other versions
KR20090061511A (en
Inventor
이필호
박용광
김선대
Original Assignee
강원대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강원대학교산학협력단 filed Critical 강원대학교산학협력단
Priority to KR1020070128539A priority Critical patent/KR100941174B1/en
Publication of KR20090061511A publication Critical patent/KR20090061511A/en
Application granted granted Critical
Publication of KR100941174B1 publication Critical patent/KR100941174B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/48Silver or gold
    • B01J23/50Silver

Abstract

본 발명은 퓨란 유도체와 은 촉매를 이용한 이의 제조방법에 관한 것으로, 보다 상세하게는 알렌인-1,6-다이올 유도체를 은(Ag) 촉매 조건에서 산소-탄소간의 선택적인 분자내 고리화 반응을 수행하여 제조된 신규 구조의 하기 화학식 1로 표시되는 퓨란 유도체와 이의 제조방법에 관한 것이다.The present invention relates to a furan derivative and a method for preparing the same using a silver catalyst. More specifically, an intramolecular cyclization reaction between allene-in-1,6-diol derivatives under oxygen (Ag) catalyst conditions is performed. It relates to a furan derivative represented by the following formula (1) of the novel structure prepared by performing and a method for producing the same.

Figure 112009064553141-pat00036
Figure 112009064553141-pat00036

상기 화학식 1에서, A 와 B는 각각 발명의 상세한 설명에서 정의한 바와 같다. In Formula 1, A and B are as defined in the detailed description of the invention, respectively.

은촉매, 알렌인-1,6-다이올, 분자내 고리화반응, 퓨란 Silver catalyst, allene-1,6-diol, intramolecular cyclization reaction, furan

Description

퓨란 유도체와 은 촉매를 이용한 이의 제조방법{Furan derivatives, and process for preparing them using Ag catalyst}Furan derivatives, and process for preparing them using Ag catalyst}

본 발명은 은(Ag) 촉매 조건에서 알렌인-1,6-다이올 유도체를 산소-탄소간의 선택적인 분자내 고리화 반응시켜 제조된 신규 구조의 퓨란 유도체와 이의 제조방법에 관한 것이다.The present invention relates to a furan derivative of a novel structure prepared by selective intramolecular cyclization reaction of allene-in-1,6-diol derivatives under oxygen (Ag) catalyst condition and a method for preparing the same.

퓨란 유도체는 중요 천연물을 합성하는데 기본적인 골격을 이루고 있으며, 생물학적 활성을 가지고 있기 때문에 의약품이나 향수 또는 향신료 등을 합성하는 중간체로서 많이 사용되고 있다. Furan derivatives form a basic skeleton for synthesizing important natural products, and because they have biological activities, are widely used as intermediates for synthesizing pharmaceuticals, perfumes, spices, and the like.

퓨란 유도체의 제조방법에 대한 연구는 광범위하게 이루어져 있고, 유기합성 화학자들에 의해 많은 합성법이 개발되어 많은 문헌에 보고되어 있다. 특히 전이금속 예를 들면 팔라듐(Pd), 크롬(Cr), 구리(Cu) 등을 촉매로 이용한 퓨란 유도체의 합성방법은 입체 선택성이나 자리선택성이 뛰어난 장점이 있는 것으로 잘 알려져 있다. 불포화 화합물과 친핵체와의 반응을 통한 유기화합물의 합성에 있 어, 은(Ag)이 루이스 산으로 작용하여 불포화 탄소의 π-결합을 활성화시켜 친핵체와 반응성을 향상시키는 것에 대해서는 문헌에 공지되어 있다. 그러나, 은(Ag) 촉매를 이용하여 퓨란 화합물을 합성하는 방법은 흔치않다.Research on the preparation of furan derivatives is extensive, many synthesis methods have been developed by organic synthesis chemists and reported in many documents. In particular, the synthesis of furan derivatives using transition metals such as palladium (Pd), chromium (Cr), copper (Cu), and the like as catalysts is well known to have excellent stereoselectivity and site selectivity. In the synthesis of organic compounds through the reaction of unsaturated compounds with nucleophiles, silver (Ag) is known in the literature to act as a Lewis acid to activate the π-bond of unsaturated carbon to enhance its reactivity with nucleophiles. However, the synthesis of furan compounds using silver (Ag) catalysts is rare.

그러나 최근에는 은(Ag) 촉매의 뛰어난 반응성을 이용한 많은 유기합성법이 개발되어 있다. [J. Org. Chem. 1984, 49, 3762; Angew. Chem. Int. Ed. Engl. 1980, 19, 461; Tetrahedron. 1987, 43, 3309; Chem. Eur. J. 1997, 3, 1170; J. Org. Chem. 2000, 65, 4198; J. Am. Chem. Soc. 2000, 122, 4992; Org. Lett. 2000, 2, 297; Org. Lett. 2001, 3, 2537; Org. Lett. 2002, 4, 289; Org. Lett. 2002, 4, 1387; J. Am. Chem. Soc. 2004, 126, 11164; Org. Lett. 2005, 7, 3367].Recently, however, many organic synthesis methods have been developed utilizing the excellent reactivity of silver (Ag) catalysts. J. Org. Chem. 1984 , 49 , 3762; Angew. Chem. Int. Ed. Engl . 1980 , 19 , 461; Tetrahedron . 1987 , 43 , 3309; Chem. Eur. J. 1997 , 3 , 1170; J. Org. Chem. 2000 , 65 , 4198; J. Am. Chem. Soc . 2000 , 122 , 4992; Org. Lett. 2000 , 2 , 297; Org. Lett . 2001 , 3 , 2537; Org. Lett . 2002 , 4 , 289; Org. Lett. 2002 , 4 , 1387 ; J. Am. Chem. Soc . 2004 , 126 , 11164; Org. Lett . 2005 , 7 , 3367].

본 발명자들은 은(Ag) 촉매가 알렌인-1,6-다이올 유도체의 분자내 고리화 반응에서 탁월한 입체 선택성이나 자리선택성을 나타냄을 확인함으로써, 본 발명을 완성하게 되었다. 현재까지 보고된 바에 의하면, 은(Ag) 촉매를 이용한 분자내 고리화 반응에 의해 알렌인-1,6-다이올 화합물로부터 퓨란 유도체를 합성한 예는 어느 문헌에서도 보고된 바가 없다. The present inventors have completed the present invention by confirming that the silver (Ag) catalyst exhibits excellent stereoselectivity and site selectivity in the intramolecular cyclization reaction of the allene-1,6-diol derivative. As reported so far, no examples of synthesizing furan derivatives from allene-1,6-diol compounds by intramolecular cyclization using silver (Ag) catalysts have been reported in any literature.

본 발명은 신규 구조의 알렌인-1,6-다이올 유도체를 제공하는데 그 목적이 있다.It is an object of the present invention to provide an allene-1,6-diol derivative having a novel structure.

또한 본 발명은 은(Ag) 촉매로 이용하여 알렌인-1,6-다이올 유도체의 고리화 반응을 수행하여 퓨란 유도체를 선택적으로 제조하는 방법을 제공하는데 다른 목적이 있다.Another object of the present invention is to provide a method for selectively preparing a furan derivative by carrying out a cyclization reaction of an allene-1,6-diol derivative using a silver (Ag) catalyst.

본 발명은 하기 화학식 1로 표시되는 퓨란 유도체와 이의 제조방법을 그 특징으로 한다. The present invention is characterized by a furan derivative represented by the following formula (1) and a method for producing the same.

[화학식 1][Formula 1]

Figure 112009064553141-pat00037
Figure 112009064553141-pat00037

상기 화학식 1에서, A 및 B는 각각 수소원자; C1-C6 알킬기; C5-C8 사이클로알킬기; 할로겐, 니트로, C1-C6 알킬, C1-C6 알콕시, C2-C6 알킬카보닐, C2-C6 알콕시카보닐 및 C2-C6 알카노에이트 중에서 선택된 치환체가 치환 또는 비치환된 페닐기; 페닐-C1-C6 알킬렌기; 또는 산소원자를 포함한 5 내지 8각형 헤테로싸이클기를 나타낸다.In Formula 1, A and B are each a hydrogen atom; C 1 -C 6 Alkyl groups; C 5 -C 8 Cycloalkyl group; Halogen, nitro, C 1 -C 6 Alkyl, C 1 -C 6 Alkoxy, C 2 -C 6 Alkylcarbonyl, C 2 -C 6 A phenyl group in which a substituent selected from alkoxycarbonyl and C 2 -C 6 alkanoate is substituted or unsubstituted; Phenyl-C 1 -C 6 alkylene group; Or a 5 to 8 pentagonal heterocycle group containing an oxygen atom.

본 발명은 상기 화학식 1로 표시되는 신규 구조의 퓨란 유도체와, 상기한 신규 화합물을 알렌인-1,6-다이올 유도체를 출발물질로 사용하여 은(Ag) 촉매하에서 선택적인 분자내 고리화 반응시켜 제조하는 방법에 관한 것이다.The present invention provides a selective intramolecular cyclization reaction under a silver (Ag) catalyst using a furan derivative having a novel structure represented by Chemical Formula 1 and the above-mentioned novel compound as an allene-1-1,6-diol derivative. It relates to a method for producing.

본 발명에 따른 상기 화학식 1로 표시되는 퓨란 유도체에 있어서의 치환기를 좀 더 자세히 설명하면 다음과 같다.Hereinafter, the substituents in the furan derivative represented by Chemical Formula 1 according to the present invention will be described in more detail.

본 발명에서의 '알킬'은 탄소수 1 내지 6의 직쇄상 또는 분쇄상의 포화된 탄소사슬을 나타낸다. 구체적으로 메틸, 에틸, n-프로필, 이소프로필, 부틸, 이소부틸, 2차-부틸, t-부틸, 펜틸, 네오-펜틸, 헥실, 이소헥실 등이 포함될 수 있다. "Alkyl" in the present invention represents a straight or pulverized saturated carbon chain having 1 to 6 carbon atoms. Specifically, methyl, ethyl, n-propyl, isopropyl, butyl, isobutyl, secondary-butyl, t-butyl, pentyl, neo-pentyl, hexyl, isohexyl and the like can be included.

본 발명에서의 '사이클로알킬'은 5 내지 8 개의 고리 탄소 원자를 갖는 포화 또는 부분 포화된 모노- 또는 폴리-카보사이클릭 고리를 포함하는 그룹을 나타낸다. 구체적으로 사이클로알킬은 사이클로펜틸, 사이클로펜테닐, 사이클로헥실, 사이클로헥세닐, 사이클로헵틸 등이 포함될 수 있다.'Cycloalkyl' in the present invention refers to a group comprising saturated or partially saturated mono- or poly-carbocyclic rings having 5 to 8 ring carbon atoms. Specifically, cycloalkyl may include cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cycloheptyl, and the like.

본 발명에서의 '헤테로싸이클'은 헤테로원자로서 산소를 포함하여 5 내지 8개의 원소로 이루어진 방향족 탄화수소 고리를 일컫는다. 구체적으로는 퓨란, 피란, 이소벤조퓨란, 크로멘 등이 포함될 수 있다.Heterocycle in the present invention refers to an aromatic hydrocarbon ring composed of 5 to 8 elements including oxygen as a hetero atom. Specifically, furan, pyran, isobenzofuran, chromene, and the like may be included.

본 발명에 따른 상기 화학식 1로 표시되는 퓨란 유도체에 있어 바람직한 화합물은, 상기 A 및 B가 각각 수소원자; C1-C4 알킬기; C5-C7 사이클로알킬기; 페닐기; 또는 할로겐, 니트로, C1-C4 알킬, C1-C4 알콕시, C2-C4 알킬카보닐, C2-C4 알콕시카보닐 및 C2-C4 알카노에이트 중에서 선택된 치환체가 치환된 페닐기이며; 다만 A와 B가 동시에 수소원자인 화합물은 제외한다.Preferred compounds in the furan derivative represented by Formula 1 according to the present invention, wherein A and B are each a hydrogen atom; C 1 -C 4 alkyl group; C 5 -C 7 cycloalkyl group; Phenyl group; Or a substituent selected from halogen, nitro, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 2 -C 4 alkylcarbonyl, C 2 -C 4 alkoxycarbonyl and C 2 -C 4 alkanoate Phenyl group; Except for compounds in which A and B are hydrogen atoms at the same time.

본 발명에 따른 상기 화학식 1로 표시되는 퓨란 유도체에 있어 더욱 바람직한 화합물은, A 및 B가 각각 수소원자; 메틸기; 에틸기; n-프로필기; 이소프로필 기; 부틸기; 이소부틸기; 헥실기; 사이클로헥실기; 페닐기; 또는 클로로, 요오도, 브로모, 니트로, 메틸, 에틸, n-프로필, 이소프로필, 부틸, 메톡시, 에톡시, 프로폭시, 부톡시, 아세틸, 메톡시카보닐, 에톡시카보닐 및 아세톡시 중에서 선택된 치환체가 치환된 페닐기를 나타내고; 다만 A와 B가 동시에 수소원자인 화합물은 제외한다.More preferred compounds in the furan derivative represented by Formula 1 according to the present invention, A and B are each a hydrogen atom; Methyl group; Ethyl group; n-propyl group; Isopropyl group; Butyl group; Isobutyl group; Hexyl group; Cyclohexyl group; Phenyl group; Or chloro, iodo, bromo, nitro, methyl, ethyl, n-propyl, isopropyl, butyl, methoxy, ethoxy, propoxy, butoxy, acetyl, methoxycarbonyl, ethoxycarbonyl and acetoxy A substituent selected from represents a substituted phenyl group; Except for compounds in which A and B are hydrogen atoms at the same time.

본 발명에 따른 상기 화학식 1로 표시되는 퓨란 유도체를 구체적으로 예시하면 다음과 같다: 1-(5-프로필-4-비닐퓨란-2-일)-펜탄-2-올, 1-시클로헥실-2-(5-시클로헥실-4-비닐퓨란-2-일)-에탄올, 1-페닐-2-(5-페닐-4-비닐퓨란-2-일)-에탄올, 1-(4-클로로페닐)-2-[5-(4-클로로페닐)-4-비닐퓨란-2-일]-에탄올, 1-(3-메톡시페닐)-2-[5-(3-메톡시페닐)-4-비닐퓨란-2-일]-에탄올, 또는 1-(4-아세틸페닐)-2-[5-(4-아세틸페닐)-4-비닐퓨란-2-일]-에탄올이다. Specific examples of the furan derivative represented by Chemical Formula 1 according to the present invention are as follows: 1- (5-propyl-4-vinylfuran-2-yl) -pentan-2-ol and 1-cyclohexyl-2 -(5-cyclohexyl-4-vinylfuran-2-yl) -ethanol, 1-phenyl-2- (5-phenyl-4-vinylfuran-2-yl) -ethanol, 1- (4-chlorophenyl) -2- [5- (4-chlorophenyl) -4-vinylfuran-2-yl] -ethanol, 1- (3-methoxyphenyl) -2- [5- (3-methoxyphenyl) -4- Vinylfuran-2-yl] -ethanol, or 1- (4-acetylphenyl) -2- [5- (4-acetylphenyl) -4-vinylfuran-2-yl] -ethanol.

한편, 본 발명은 상기 화학식 1로 표시되는 퓨란 유도체의 제조방법을 권리범위로 포함한다.On the other hand, the present invention includes a method for producing a furan derivative represented by the formula (1) as a scope.

본 발명에 따른 제조방법은 하기 화학식 2로 표시되는 알렌인-1,6-다이올 화합물을 은(Ag) 촉매 조건에서 분자내 고리화 반응을 수행하여 이루어진다.The preparation method according to the present invention is performed by performing an intramolecular cyclization reaction of an allene-1,6-diol compound represented by Formula 2 under silver (Ag) catalyst conditions.

[화학식 2][Formula 2]

Figure 112007089104014-pat00003
Figure 112007089104014-pat00003

상기 화학식 2에서, A, B는 각각 상기에서 정의한 바와 같다.In Formula 2, A and B are as defined above, respectively.

본 발명의 제조방법은 산소-탄소간의 분자내 고리화 반응을 수행함에 있어, 은(Ag) 촉매의 선택 사용에 의해 선택적인 분자내 고리화 반응을 수행함으로써 상기 화학식 1로 표시되는 퓨란 유도체를 합성한데 그 특징이 있다. 본 발명이 사용하는 은(Ag) 촉매는 은이온(Ag+)을 함유하는 은 화합물이라면 어느 것을 사용하여도 무방하며, 구체적으로는 AgOTf, AgBF4, AgSbF6, AgAsF6로 이루어진 군에서 선택되는 것이 바람직하며, 본 발명의 실시예에서는 AgOTf를 촉매로 사용한 예를 대표적으로 예시하였다. 상기한 은(Ag) 촉매는 촉매량으로서 소량 첨가하더라도 이의 첨가효과는 충분히 얻을 수 있으므로, 본 발명은 은(Ag) 촉매의 사용량에 있어서 특별한 제한을 두지는 않으나, 여러 가지 여건을 고려하여 상기 화학식 3으로 표시되는 알렌인-1,6-다이올 화합물에 대하여 0.01 내지 0.5 당량 범위로 사용하는 것이 좋다.In the preparation method of the present invention, in performing the intramolecular cyclization reaction between oxygen and carbon, a furan derivative represented by Chemical Formula 1 is synthesized by performing the selective intramolecular cyclization reaction by the selective use of silver (Ag) catalyst. There is a characteristic. The silver (Ag) catalyst used in the present invention may be any silver compound containing silver ions (Ag + ), specifically, selected from the group consisting of AgOTf, AgBF 4 , AgSbF 6 , and AgAsF 6 . Preferably, in the embodiment of the present invention, the example using AgOTf as a catalyst representatively. The silver (Ag) catalyst can be sufficiently added even if a small amount is added as a catalytic amount, the present invention is not particularly limited in the amount of the silver (Ag) catalyst used, in consideration of various conditions of the formula (3) It is preferable to use it in 0.01-0.5 equivalent range with respect to the allene 1, 6- diol compound represented by the following.

본 발명의 고리화 반응에 사용되는 용매는 통상의 유기용매이며 아세토나이트릴, 니트로메탄을 포함한 지방족 니트릴류, 다이클로로메탄, 다이클로로에탄을 포함한 할로겐화 지방족 탄화수소류 등을 사용할 수 있으며, 본 발명의 실시예에서는 대표적으로 다이클로로메탄을 사용하였다.The solvent used in the cyclization reaction of the present invention is a conventional organic solvent, and may be used acetonitrile, aliphatic nitriles including nitromethane, dichloromethane, halogenated aliphatic hydrocarbons including dichloroethane, and the like. In the examples, dichloromethane is typically used.

고리화 반응은 15℃ 내지 30℃ 온도범위에서 수행하며, 실온에서 반응을 수행하더라도 반응은 충분히 완결시킬 수 있다.The cyclization reaction is carried out in the temperature range of 15 ℃ to 30 ℃, even if the reaction is carried out at room temperature can be sufficiently completed.

고리화 반응 시간은 반응물질, 용매의 종류 및 용매의 양에 따라 달라질 수 있으며, TLC 등을 통하여 출발물질은 알렌인-1,6-다이올 화합물이 모두 소모되었음을 확인 후 반응을 완결시키도록 한다. 반응이 완결되면 감압하에서 용매를 증류시킨 후 관 크로마토그래피 등의 통상의 방법을 통하여 목적물을 분리 정제할 수 있다.The cyclization reaction time may vary depending on the reactants, the type of solvent, and the amount of solvent. The starting material through TLC confirms that allene-1,6-diol compounds are consumed and then completes the reaction. . After the reaction is completed, the solvent may be distilled off under reduced pressure, and then the target product may be separated and purified through a conventional method such as column chromatography.

또한, 본 발명의 분자내 고리화 반응을 수행하는데 있어 출발물질로 사용되는 상기 화학식 2로 표시되는 알렌인-1,6-다이올 화합물 역시 신규 화합물이다. 본 발명자들은 상기 화학식 2로 표시되는 알렌인-1,6-다이올 화합물과 이 화합물의 제조방법에 대하여 대한민국 특허출원 제10-2007-0058871호로서 특허출원한 바도 있으므로, 상기 화학식 2로 표시되는 화합물의 구체적인 제조방법에 대해서는 기출원된 명세서를 참조하도록 한다.In addition, the allene-in-1,6-diol compound represented by Chemical Formula 2 used as a starting material in carrying out the intramolecular cyclization reaction of the present invention is also a novel compound. The present inventors have applied for the allene-in-1,6-diol compound represented by Chemical Formula 2 and a method for preparing the compound as Korean Patent Application No. 10-2007-0058871, which is represented by Chemical Formula 2 For specific preparation methods of the compounds, reference should be made to the previously published specification.

상기 화학식 2로 표시되는 알렌인-1,6-다이올 화합물은 ⅰ)하기 화학식 3으로 표시되는 1,6-다이브로모-2,4-헥사다이인과 인듐(In)을 반응시켜 유기인듐 시약을 제조하고, ⅱ)제조된 유기인듐 시약을 분리 정제한 후에 또는 분리 정제과정 없이 인 시츄(in situ)로 하기 화학식 4로 표시되는 카보닐 화합물을 반응시켜, 상기 화학식 2로 표시되는 알렌인-1,6-다이올 유도체를 제조할 수 있다.The allene-in-1,6-diol compound represented by Formula 2 may be reacted with an organic indium reagent by reacting indium (In) with 1,6-dibromo-2,4-hexadiin represented by Formula 3 below: And (ii) reacting the carbonyl compound represented by the following Formula 4 with or without in situ after separation and purification of the prepared organic indium reagent. 1,6-diol derivatives can be prepared.

Figure 112007089104014-pat00004
Figure 112007089104014-pat00004

Figure 112007089104014-pat00005
Figure 112007089104014-pat00005

상기 화학식 4에서, A와 B는 각각 상기 화학식 1에서 정의한 바와 같다.In Formula 4, A and B are as defined in Formula 1, respectively.

상기 반응에서 인듐(In)은 상기 화학식 3으로 표시되는 1,6-다이브로모-2,4-헥사다이인에 대하여 2 내지 3 당량, 바람직하기로는 2.1 내지 2.5 당량 범위로 사용하도록 한다. 반응 용매는 통상의 유기용매이며 다이메틸포름아미드(DMF), 테트라하이드로퓨란(THF)를 사용하며, 바람직하기로는 테트라하이드로퓨란(THF)를 사용하여 수행하는 것이다. 반응 온도는 15℃ 내지 30℃를 유지하도록 하며, 상온에서도 반응은 원활하게 수행될 수 있다. 반응 시간은 반응물질, 용매의 종류 및 용매의 양에 따라 달라질 수 있으며, TLC 등을 통하여 출발물질이 모두 소모되었음을 확인 후 반응을 완결시키도록 한다. 반응이 완결되면, 추출과정을 통해 감압하에서 용매를 증류시킨 후 관 크로마토그래피 등의 통상의 방법을 통하여 목적물을 분리 정제할 수도 있다. 또한, 상기 화학식 4로 표시되는 카보닐 화합물이 알데하이드 화합물인 경우, 할라이드 금속염을 첨가하는 것이 보다 바람직할 수 있으며, 할라이드 금속염은 상기 화학식 2로 표시되는 1,6-다이브로모-2,4-헥사다이인에 대하여 2 내지 3 당량, 바람직하기로는 2.1 내지 2.5 당량 범위로 사용하도록 한다. 할라이드 금속염은 알칼리 금속의 할라이드 화합물을 일컫는 것이며, 구체적으로 요오도화 리튬(LiI), 요오도화 나트륨(NaI), 요오도화 칼륨(KI), 염화 리튬(LiCl), 염화 나트륨(NaCl), 염화 칼륨(KCl) 등이 사용될 수 있다.Indium (In) in the reaction is used in the range of 2 to 3 equivalents, preferably 2.1 to 2.5 equivalents relative to 1,6-dibromo-2,4-hexadiyne represented by the formula (3). The reaction solvent is a conventional organic solvent, and it is performed using dimethylformamide (DMF) and tetrahydrofuran (THF), preferably using tetrahydrofuran (THF). The reaction temperature is to maintain 15 ℃ to 30 ℃, the reaction can be carried out smoothly even at room temperature. The reaction time may vary depending on the reactants, the type of solvent, and the amount of the solvent, and then complete the reaction after confirming that all the starting materials are consumed through TLC. After the reaction is completed, the solvent may be distilled off under reduced pressure through the extraction process, and then the target product may be separated and purified through conventional methods such as column chromatography. In addition, when the carbonyl compound represented by Chemical Formula 4 is an aldehyde compound, it may be more preferable to add a halide metal salt, and the halide metal salt may be 1,6-dibromo-2,4-hexa represented by Chemical Formula 2 above. The diyne is used in the amount of 2 to 3 equivalents, preferably in the range of 2.1 to 2.5 equivalents. The halide metal salt refers to a halide compound of alkali metal, and specifically, lithium iodide (LiI), sodium iodide (NaI), potassium iodide (KI), lithium chloride (LiCl), sodium chloride (NaCl), potassium chloride ( KCl) and the like can be used.

이상에서 설명한 바와 같은 본 발명은 하기의 제조예 및 실시예를 통하여 보 다 상세하게 설명하지만, 하기의 제조예 및 실시예들은 본 발명에 대한 이해를 돕기 위한 것으로서, 본 발명의 범위가 여기에 국한된 것은 아니다.The present invention as described above will be described in more detail through the following Preparation Examples and Examples, but the following Preparation Examples and Examples to help the understanding of the present invention, the scope of the present invention is limited thereto It is not.

[제조예] [Production example]

본 발명이 출발물질로 사용하는 상기 화학식 2로 표시되는 알렌인-1,6-다이올 화합물의 대표적인 합성예이다.The present invention is a typical synthesis example of the allene-1,6-diol compound represented by the formula (2) used as a starting material.

제조예 1. 3-비닐리덴-4-옥틴-2,7-다이올의 제조Preparation Example 1 Preparation of 3-vinylidene-4-octin-2,7-diol

Figure 112007089104014-pat00006
Figure 112007089104014-pat00006

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 아세틸 알데하이드(44 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 1 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 3-비닐리덴-4-옥틴-2,7-다이올(70 mg, 84%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and then acetyl aldehyde (44 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 1 hour, followed by 10% aqueous hydrochloric acid solution (3 mL). Was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 3-vinylidene-4-octyne-2,7-diol (70 mg, 84%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 5.08(s, 2H), 4.33(q, J = 6.25 Hz, 1H), 4.03-3.96(m, 1H), 2.71(s, 2H), 2.59-2.45(m, 1H), 1.36(d, J = 6.25 Hz, 3H), 1.28(d, J = 6.10 Hz, 3H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 5.08 (s, 2H), 4.33 (q, J = 6.25 Hz, 1H), 4.03-3.96 (m, 1H), 2.71 (s, 2H) , 2.59-2.45 (m, 1H), 1.36 (d, J = 6.25 Hz, 3H), 1.28 (d, J = 6.10 Hz, 3H)

제조예 2. 5-비닐리덴-6-도데신-4,9-다이올의 제조Preparation Example 2 Preparation of 5-vinylidene-6-dodecine-4,9-diol

Figure 112007089104014-pat00007
Figure 112007089104014-pat00007

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 부티릴 알데하이드(106 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 1 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 5-비닐리덴-6-도데신-4,9-다이올(95 mg, 85%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL) and stirred at room temperature for 15 minutes. Butyryl aldehyde (106 mg, 1.0 mmol) was added to the reaction solvent, which was stirred at room temperature for 1 hour, followed by 10% aqueous hydrochloric acid solution (3 mL). ) To terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 5-vinylidene-6-dodecine-4,9-diol (95 mg, 85%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 5.07(s, 2H), 4.13(t, J = 6.42 Hz, 1H), 3.82-3.76(m, 1H), 2.59(dd, J = 4.60, 4.60 Hz, 1H), 2.47(dd, 6.81, 6.81 Hz, 1H), 1.93(s, 2H), 1.72-1.63(m, 4H), 1.60-1.25(m, 4H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 5.07 (s, 2H), 4.13 (t, J = 6.42 Hz, 1H), 3.82-3.76 (m, 1H), 2.59 (dd, J = 4.60, 4.60 Hz, 1H), 2.47 (dd, 6.81, 6.81 Hz, 1H), 1.93 (s, 2H), 1.72-1.63 (m, 4H), 1.60-1.25 (m, 4H)

제조예 3. 1,6-다이사이클로헥실-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 3 Preparation of 1,6-dicyclohexyl-2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00008
Figure 112007089104014-pat00008

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 사이클로헥실카바알데하이드(112 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 1 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-다이사이클로헥실-2-비닐리덴-3-헥신-1,6-다이올(95 mg, 63%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and cyclohexylcarbaaldehyde (112 mg, 1.0 mmol) was added to the reaction solvent, which was stirred at room temperature for 1 hour, followed by 10% aqueous hydrochloric acid solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-dicyclohexyl-2-vinylidene-3-hexine-1,6-diol (95 mg, 63%).

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 5.03(s, 2H), 3.82(d, J = 7.17 Hz, 1H), 3.53-3.49(m, 1H), 2.60(dd, J = 4.27, 4.27 Hz, 1H), 2.51(dd, J = 6.78, 7.39 Hz, 1H) 2.08(s, 2H), 1.93(t, J = 14.2 Hz, 2H), 1.78-1.65(m, 8H), 1.64-1.45(m, 2H), 1.28-1.12(m, 6H), 1.08-0.98(m, 4H) 1 H NMR (400 MHz, CDCl 3, 25 ° C, TMS) δ 5.03 (s, 2H), 3.82 (d, J = 7.17 Hz, 1H), 3.53-3.49 (m, 1H), 2.60 (dd, J = 4.27, 4.27 Hz, 1H), 2.51 (dd, J = 6.78, 7.39 Hz, 1H) 2.08 (s, 2H), 1.93 (t, J = 14.2 Hz, 2H), 1.78-1.65 (m, 8H), 1.64 -1.45 (m, 2H), 1.28-1.12 (m, 6H), 1.08-0.98 (m, 4H)

제조예 4. 1,6-다이페닐-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 4 Preparation of 1,6-diphenyl-2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00009
Figure 112007089104014-pat00009

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 벤즈알데하이드(106 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 1 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-다이페닐-2-비닐리덴-3-헥신-1,6-다이올(125 mg, 63%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and benzaldehyde (106 mg, 1.0 mmol) was added to the reaction solvent, which was stirred at room temperature for 1 hour, followed by 10% aqueous hydrochloric acid solution (3 mL). Was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 1,6-diphenyl-2-vinylidene-3-hexine-1,6-diol (125 mg, 63%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.36-7.25(m,10H), 5.21(d, J = 2.06 Hz, 1H), 5.10(s, 2H), 4.75(t, J = 6.3 Hz, 1H), 2.69(d, J = 6.3 Hz, 2H), 2.27(s, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.36-7.25 (m, 10H), 5.21 (d, J = 2.06 Hz, 1H), 5.10 (s, 2H), 4.75 (t, J = 6.3 Hz, 1H), 2.69 (d, J = 6.3 Hz, 2H), 2.27 (s, 2H)

제조예 5. 1,10-다이페닐-2-비닐리덴-1,9-데카다이엔-5-인-3,8-다이올의 제조Preparation Example 5 Preparation of 1,10-diphenyl-2-vinylidene-1,9-decadiene-5-phosphor-3,8-diol

Figure 112007089104014-pat00010
Figure 112007089104014-pat00010

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 트랜스-신남알데하이드(132 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 1 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,10-다이페닐-2-비닐리덴-1,9-데카다이엔-5-인-3,8-다이올(153 mg, 70%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and then trans-cinnaaldehyde (132 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 1 hour, followed by 10% aqueous hydrochloric acid solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 1,10-diphenyl-2-vinylidene-1,9-decadiene-5-phosphine-3,8-diol (153 mg, 70%) Got.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.40-7.34(m, 4H), 7.32-7.28(m, 4H), 7.25-7.22(m, 2H), 6.65(dd, J = 11.4, 11.4 Hz, 2H), 6.28(ddd, J = 15.9, 11.6, 6.2 Hz, 2H), 5.15(s, 2H), 4.81(d, J = 6.2 Hz, 1H), 2.78-2.65(m, 2H), 2.20(s, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.40-7.34 (m, 4H), 7.32-7.28 (m, 4H), 7.25-7.22 (m, 2H), 6.65 (dd, J = 11.4 , 11.4 Hz, 2H), 6.28 (ddd, J = 15.9, 11.6, 6.2 Hz, 2H), 5.15 (s, 2H), 4.81 (d, J = 6.2 Hz, 1H), 2.78-2.65 (m, 2H) , 2.20 (s, 2H)

제조예 6. 1,6-비스-(4-클로로페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 6 Preparation of 1,6-bis- (4-chlorophenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00011
Figure 112007089104014-pat00011

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-클로로벤즈알데하이드(140 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 1 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 6-비스-(4-클로로페닐)-2-비닐리덴-3-헥신-1,6-다이올(154 mg, 86%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and 4-chlorobenzaldehyde (140 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 1 hour, followed by 10% aqueous hydrochloric acid solution ( 3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 6-bis- (4-chlorophenyl) -2-vinylidene-3-hexine-1,6-diol (154 mg, 86%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.29-7.26(m, 6H), 7.21-7.18(m, 2H), 5.16(s, 1H), 5.09(s, 2H), 4.76-4.72(m, 1H), 2.82(s, 2H), 2.72(d, J = 5.55 Hz, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.29-7.26 (m, 6H), 7.21-7.18 (m, 2H), 5.16 (s, 1H), 5.09 (s, 2H), 4.76- 4.72 (m, 1H), 2.82 (s, 2H), 2.72 (d, J = 5.55 Hz, 2H)

제조예 7. 1,6-비스-(2-요오도페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 7 Preparation of 1,6-bis- (2-iodophenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00012
Figure 112007089104014-pat00012

질소분위기 하에서 인듐(63 mg, 0.55 mmol), 염화리튬(74 mg, 0.55 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(65 mg. 0.275 mmol)을 THF(1.0 mL)에 녹인 후 실온에서 15분간 교반시킨 후 2-요오도벤즈알데하이드(116 mg, 1.0 mmol)를 THF(0.5 mL)에 녹인 후 반응용매에 첨가하여 실온에서 4 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(2-요오도페닐)-2-비닐리덴-3-헥신-1,6-다이올(104 mg, 77%)을 얻었다.Dissolve indium (63 mg, 0.55 mmol) and lithium chloride (74 mg, 0.55 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (65 mg). 0.275 mmol) was dissolved in THF (1.0 mL), stirred at room temperature for 15 minutes, and 2-iodobenzaldehyde (116 mg, 1.0 mmol) was dissolved in THF (0.5 mL) and added to the reaction solvent to obtain 4 at room temperature. After stirring for 10 hours, 10% aqueous hydrochloric acid solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. After the solvent was removed, the residue was separated by column chromatography to obtain the title compound 1,6-bis- (2-iodophenyl) -2-vinylidene-3-hexine-1,6-diol (104 mg, 77%). Got it.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.69-7.63(m, 4H), 7.10(d, J = 8.05 Hz, 2H), 7.05-7.01(m, 2H), 5.14(s, 1H), 5.12(s, 2H), 4.73-4.71(m, 1H), 2.67(d, J = 6.75 Hz, 2H), 2.35(s, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.69-7.63 (m, 4H), 7.10 (d, J = 8.05 Hz, 2H), 7.05-7.01 (m, 2H), 5.14 (s, 1H), 5.12 (s, 2H), 4.73-4.71 (m, 1H), 2.67 (d, J = 6.75 Hz, 2H), 2.35 (s, 2H)

제조예 8. 1,6-비스-(2-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 8 Preparation of 1,6-bis- (2-methoxyphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00013
Figure 112007089104014-pat00013

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 2-메톡시벤즈알데하이드(68 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 8 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(2-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올(71 mg, 82%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (1.5 mL), stirred at room temperature for 15 minutes, and 2-methoxybenzaldehyde (68 mg, 0.5 mmol) was added to the reaction solvent and stirred at room temperature for 8 hours, followed by 10% aqueous hydrochloric acid solution. (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-bis- (2-methoxyphenyl) -2-vinylidene-3-hexine-1,6-diol (71 mg, 82%) as a title compound. Got it.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.33-7.29(m, 2H), 7.27-7.22(m, 2H), 6.97-6.92(m, 2H), 6.90-6.84(m, 2H), 5.41(s, 1H), 5.03-4.97(m, 3H), 3.83(s, 3H), 3.81(s, 3H), 3.22(s, 1H), 2.86-2.81(m, 2H), 2.66(dd, J = 7.56, 7.61 Hz, 1H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.33-7.29 (m, 2H), 7.27-7.22 (m, 2H), 6.97-6.92 (m, 2H), 6.90-6.84 (m, 2H ), 5.41 (s, 1H), 5.03-4.97 (m, 3H), 3.83 (s, 3H), 3.81 (s, 3H), 3.22 (s, 1H), 2.86-2.81 (m, 2H), 2.66 ( dd, J = 7.56, 7.61 Hz, 1H)

제조예 9. 1,6-비스-(3-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 9 Preparation of 1,6-bis- (3-methoxyphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00014
Figure 112007089104014-pat00014

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 3-메톡시벤즈알데하이드(136 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 6 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(3-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올(142 mg, 81%)을 얻었다. Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (1.5 mL), stirred at room temperature for 15 minutes, and 3-methoxybenzaldehyde (136 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 6 hours, followed by 10% aqueous hydrochloric acid solution. (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-bis- (3-methoxyphenyl) -2-vinylidene-3-hexine-1,6-diol (142 mg, 81%) as a title compound. Got it.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.28-7.21(m, 4H), 6.98-6.95(m, 2H), 6.95-6.80(m, 2H), 5.19(s, 1H), 5.11(s, 2H), 4.76-4.73(m, 1H), 3.80(s, 3H), 3.79(s, 3H), 2.69(d, J = 6.69 Hz, 2H), 2.48(s, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.28-7.21 (m, 4H), 6.98-6.95 (m, 2H), 6.95-6.80 (m, 2H), 5.19 (s, 1H), 5.11 (s, 2H), 4.76-4.73 (m, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 2.69 (d, J = 6.69 Hz, 2H), 2.48 (s, 2H)

제조예 10. 1,6-비스-(4-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 10 Preparation of 1,6-bis- (4-methoxyphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00015
Figure 112007089104014-pat00015

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-메톡시벤즈알데하이드(136 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 3 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(4-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올(136 mg, 78%)을 얻었다. Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (1.5 mL), stirred at room temperature for 15 minutes, and 4-methoxybenzaldehyde (136 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 3 hours, followed by 10% aqueous hydrochloric acid solution. (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-bis- (4-methoxyphenyl) -2-vinylidene-3-hexine-1,6-diol (136 mg, 78%) as a title compound. Got it.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.30(d, J = 8.59 Hz, 1H), 7.29(d, J = 8.59 Hz, 1H), 7.23(d, J = 8.7 Hz, 1H), 7.22(d, J = 8.7 Hz, 1H), 6.89-6.83(m, 4H), 5.16(s, 1H), 5.11(s, 2H), 4.74(t, J = 6.32 Hz, 1H), 3.80(s, 3H), 3.79(s, 3H), 2.70(d, J = 6.32 Hz, 2H), 2.28(s, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.30 (d, J = 8.59 Hz, 1H), 7.29 (d, J = 8.59 Hz, 1H), 7.23 (d, J = 8.7 Hz, 1H ), 7.22 (d, J = 8.7 Hz, 1H), 6.89-6.83 (m, 4H), 5.16 (s, 1H), 5.11 (s, 2H), 4.74 (t, J = 6.32 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 2.70 (d, J = 6.32 Hz, 2H), 2.28 (s, 2H)

제조예 11. 1,6-비스-(4-메틸페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 11 Preparation of 1,6-bis- (4-methylphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00016
Figure 112007089104014-pat00016

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-메틸벤즈알데하이드(60 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 4 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(4-메틸페닐)-2-비닐리덴-3-헥신-1,6-다이올(69 mg, 81%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (1.5 mL), stirred at room temperature for 15 minutes, and 4-methylbenzaldehyde (60 mg, 0.5 mmol) was added to the reaction solvent and stirred at room temperature for 4 hours, followed by 10% aqueous hydrochloric acid solution ( 3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-bis- (4-methylphenyl) -2-vinylidene-3-hexine-1,6-diol (69 mg, 81%) as a title compound.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.25-7.23(m, 2H), 7.17-7.08(m, 6H), 5.15(s, 1H), 5.06(s, 2H), 4.71(t, J = 6.28 Hz, 1H), 3.03(s, 2H), 2.66(d, J = 6.28 Hz, 2H), 2.33(s, 3H), 2.32(s, 3H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.25-7.23 (m, 2H), 7.17-7.08 (m, 6H), 5.15 (s, 1H), 5.06 (s, 2H), 4.71 ( t, J = 6.28 Hz, 1H), 3.03 (s, 2H), 2.66 (d, J = 6.28 Hz, 2H), 2.33 (s, 3H), 2.32 (s, 3H)

제조예 12. 2,6-비스-(2,4,6-트리메틸페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 12 Preparation of 2,6-bis- (2,4,6-trimethylphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00017
Figure 112007089104014-pat00017

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 2,4,6-트리메틸벤즈알데하이드(74 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 34 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(2,4,6-트리메틸페닐)-2-비닐리덴-3-헥신-1,6-다이올(77 mg, 82%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (1.5 mL), stirred at room temperature for 15 minutes, and then 2,4,6-trimethylbenzaldehyde (74 mg, 0.5 mmol) was added to the reaction solvent and stirred at room temperature for 34 hours. Aqueous solution of% hydrochloric acid (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 1,6-bis- (2,4,6-trimethylphenyl) -2-vinylidene-3-hexine-1,6-diol (77 mg, 82 %) Was obtained.

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 6.80(d, J = 8.14 Hz, 4H), 5.72(q, J = 4.23 Hz, 1H), 5.13-5.09(m, 1H), 5.07(d, J = 4.46 Hz, 2H), 2.89(dd, J = 9.7, 9.7 Hz, 1H), 2.59-2.50(m, 1H), 2.37(s, 3H), 2.36(s, 3H), 2.34(s, 6H), 2.23(s, 4H), 2.22(s, 4H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 6.80 (d, J = 8.14 Hz, 4H), 5.72 (q, J = 4.23 Hz, 1H), 5.13-5.09 (m, 1H), 5.07 (d, J = 4.46 Hz, 2H), 2.89 (dd, J = 9.7, 9.7 Hz, 1H), 2.59-2.50 (m, 1H), 2.37 (s, 3H), 2.36 (s, 3H), 2.34 ( s, 6H), 2.23 (s, 4H), 2.22 (s, 4H)

제조예 13. 1,6-비스-(4-니트로페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 13 Preparation of 1,6-bis- (4-nitrophenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00018
Figure 112007089104014-pat00018

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-니트로벤즈알데하이드(151 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 15 분 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(4-니트로페닐)-2-비닐리덴-3-헥신-1,6-다이올(180 mg, 95%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and 4-nitrobenzaldehyde (151 mg, 1.0 mmol) was added to the reaction solvent, followed by stirring at room temperature for 15 minutes, followed by 10% aqueous hydrochloric acid solution ( 3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 1,6-bis- (4-nitrophenyl) -2-vinylidene-3-hexine-1,6-diol (180 mg, 95%). .

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 8.22-8.11(m, 4H), 7.59-7.49(m, 4H), 5.34(s, 1H), 5.16(s, 2H), 4.94-4.92(m, 1H), 2.96(s, 1H), 2.88(s, 1H), 2.71-2.69(m, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 8.22-8.11 (m, 4H), 7.59-7.49 (m, 4H), 5.34 (s, 1H), 5.16 (s, 2H), 4.94- 4.92 (m, 1H), 2.96 (s, 1H), 2.88 (s, 1H), 2.71-2.69 (m, 2H)

제조예 14. 1,6-비스-(3-하이드록시페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 14 Preparation of 1,6-bis- (3-hydroxyphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00019
Figure 112007089104014-pat00019

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 3-하이드록시벤즈알데하이드(122 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 8 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(3-하이드록시페닐)-2-비닐리덴-3-헥신-1,6-다이올(128 mg, 80%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (1 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (1.5 mL), stirred at room temperature for 15 minutes, and 3-hydroxybenzaldehyde (122 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 8 hours, followed by 10% aqueous hydrochloric acid solution. (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 1,6-bis- (3-hydroxyphenyl) -2-vinylidene-3-hexine-1,6-diol (128 mg, 80%). Got it.

1H NMR(400 MHz, DMSO-d6, 25℃) δ 9.24(s, 2H), 7.11-7.03(m, 2H), 6.79-6.69(m, 4H), 6.67-6.61(m, 2H), 5.70-5.67(m, 1H), 5.37(d, J = 4.35 Hz, 1H), 5.12(s, 2H), 4.91(s, 1H), 4.55-4.49(m, 1H), 2.60-2.49(m, 2H) 1 H NMR (400 MHz, DMSO-d 6 , 25 ° C.) δ 9.24 (s, 2H), 7.11-7.03 (m, 2H), 6.79-6.69 (m, 4H), 6.67-6.61 (m, 2H), 5.70-5.67 (m, 1H), 5.37 (d, J = 4.35 Hz, 1H), 5.12 (s, 2H), 4.91 (s, 1H), 4.55-4.49 (m, 1H), 2.60-2.49 (m, 2H)

제조예 15. 1,6-비스-(4-아세틸페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 15 Preparation of 1,6-bis- (4-acetylphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00020
Figure 112007089104014-pat00020

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-아세틸벤즈알데하이드(148 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 8 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 표제화합물인 1,6-비스-(4-아세틸페닐)-2-비닐리덴-3-헥신-1,6-다이올(154 mg, 82%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and 4-acetylbenzaldehyde (148 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 8 hours, followed by 10% aqueous hydrochloric acid solution ( 3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain the title compound 1,6-bis- (4-acetylphenyl) -2-vinylidene-3-hexine-1,6-diol (154 mg, 82%). .

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.95-7.89(m, 4H), 7.37(d, J = 8.23 Hz, 2H), 7.40(d, J = 8.23 Hz, 1H), 7.39(d, J = 8.23 Hz, 1H), 5.28(s, 1H), 5.15(s, 2H), 4.86(dd, J = 5.73, 4.68 Hz, 1H), 2.74(dd, J = 5.73, 4.68 Hz, 1H), 2.61(s, 1H), 2.51(s, 1H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.95-7.89 (m, 4H), 7.37 (d, J = 8.23 Hz, 2H), 7.40 (d, J = 8.23 Hz, 1H), 7.39 (d, J = 8.23 Hz, 1H), 5.28 (s, 1H), 5.15 (s, 2H), 4.86 (dd, J = 5.73, 4.68 Hz, 1H), 2.74 (dd, J = 5.73, 4.68 Hz, 1H), 2.61 (s, 1H), 2.51 (s, 1H)

제조예 16. 1,6-비스-(4-메톡시카보닐페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 16 Preparation of 1,6-bis- (4-methoxycarbonylphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00021
Figure 112007089104014-pat00021

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 메틸 4-포밀벤조에이트(164 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 7 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 1,6-비스-(4-메톡시카보닐페닐)-2-비닐리덴-3-헥신-1,6-다이올(190 mg, 82%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and methyl 4-formylbenzoate (164 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 7 hours, followed by 10% aqueous hydrochloric acid solution. (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-bis- (4-methoxycarbonylphenyl) -2-vinylidene-3-hexine-1,6-diol (190 mg, 82%). .

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 8.00-7.94(m, 4H), 7.43(d, J = 8.23 Hz, 1H), 7.42(d, J = 8.32 Hz, 1H), 7.35(d, J = 8.27 Hz, 1H), 7.34(d, J = 8.27 Hz, 1H), 5.25(s, 1H), 5.09(s, 2H), 4.82(dd, J = 5.06, 5.73 Hz, 1H), 3.90(s, 6H), 2.99(s, 2H), 2.71-2.69(m, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 8.00-7.94 (m, 4H), 7.43 (d, J = 8.23 Hz, 1H), 7.42 (d, J = 8.32 Hz, 1H), 7.35 (d, J = 8.27 Hz, 1H), 7.34 (d, J = 8.27 Hz, 1H), 5.25 (s, 1H), 5.09 (s, 2H), 4.82 (dd, J = 5.06, 5.73 Hz, 1H) , 3.90 (s, 6H), 2.99 (s, 2H), 2.71-2.69 (m, 2H)

제조예 17. 1,6-비스-(4-아세톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올의 제 조Preparation Example 17 Preparation of 1,6-bis- (4-acetoxyphenyl) -2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00022
Figure 112007089104014-pat00022

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-아세톡시벤즈알데하이드(164 mg, 1.0 mmol)를 반응용매에 첨가하여 0 ℃ 에서 24 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 1,6-비스-(4-아세톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올(140 mg, 69%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and 4-acetoxybenzaldehyde (164 mg, 1.0 mmol) was added to the reaction solvent and stirred at 0 ° C. for 24 hours, followed by 10% hydrochloric acid. An aqueous solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-bis- (4-acetoxyphenyl) -2-vinylidene-3-hexine-1,6-diol (140 mg, 69%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.40(d, J = 8.51 Hz, 2H), 7.32-7.29(m, 2H), 7.08-7.01(m, 4H), 5.21(s, 1H), 5.11(s, 2H), 4.74(dd, J = 5.42, 6.16 Hz, 1H), 2.68(d, J = 6.16 Hz, 2H), 2.29(s, 6H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.40 (d, J = 8.51 Hz, 2H), 7.32-7.29 (m, 2H), 7.08-7.01 (m, 4H), 5.21 (s, 1H), 5.11 (s, 2H), 4.74 (dd, J = 5.42, 6.16 Hz, 1H), 2.68 (d, J = 6.16 Hz, 2H), 2.29 (s, 6H)

제조예 18. 1,6-다이퓨란-2-일-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 18 Preparation of 1,6-Difuran-2-yl-2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00023
Figure 112007089104014-pat00023

질소분위기 하에서 인듐(126 mg, 1.1 mmol), 염화리튬(147 mg, 1.1 mmol)을 THF(2 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(130 mg. 0.55 mmol)을 THF(3 mL)에 녹인 후 실온에서 15분간 교반시킨 후 2-퓨릴알데하이드(96 mg, 1.0 mmol)를 반응용매에 첨가하여 실온에서 2 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 1,6-다이퓨란-2-일-2-비닐리덴-3-헥신-1,6-다이올(123 mg, 91%)을 얻었다.Dissolve indium (126 mg, 1.1 mmol) and lithium chloride (147 mg, 1.1 mmol) in THF (2 mL) solvent in a nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (130 mg). 0.55 mmol) was dissolved in THF (3 mL), stirred at room temperature for 15 minutes, and 2-furylaldehyde (96 mg, 1.0 mmol) was added to the reaction solvent and stirred at room temperature for 2 hours, followed by 10% aqueous hydrochloric acid solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-difuran-2-yl-2-vinylidene-3-hexine-1,6-diol (123 mg, 91%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.38(d, J = 10.1 Hz, 2H), 6.35-6.32(m, 3H), 6.28(t, J = 3.90 Hz, 1H), 5.20-5.18(m, 3H), 4.84(t, J = 6.10 Hz, 1H), 2.88(d, J = 6.10 Hz, 2H), 2.43(s, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.38 (d, J = 10.1 Hz, 2H), 6.35-6.32 (m, 3H), 6.28 (t, J = 3.90 Hz, 1H), 5.20 -5.18 (m, 3H), 4.84 (t, J = 6.10 Hz, 1H), 2.88 (d, J = 6.10 Hz, 2H), 2.43 (s, 2H)

제조예 19. 3,8-다이메틸-1,10-다이페닐-4-비닐리덴-5-데신-3,8-다이올의 제조Preparation Example 19 Preparation of 3,8-dimethyl-1,10-diphenyl-4-vinylidene-5-decine-3,8-diol

Figure 112007089104014-pat00024
Figure 112007089104014-pat00024

질소분위기 하에서 인듐(189 mg, 1.65 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(195 mg. 0.825 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 4-페닐-2-부탄온(75 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 7 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 3,8-다이메틸-1,10-다이페닐-4-비닐리덴-5-데신-3,8-다이올(61 mg, 65%)을 얻었다.Dissolve indium (189 mg, 1.65 mmol) in THF (1 mL) solvent under nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (195 mg. 0.825 mmol) to THF (1.5 mL). After dissolving in, stirred for 15 minutes at room temperature, 4-phenyl-2-butanone (75 mg, 0.5 mmol) was added to the reaction solvent and stirred for 7 hours at room temperature, followed by adding 10% aqueous hydrochloric acid solution (3 mL). Terminated. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and then separated by column chromatography to obtain 3,8-dimethyl-1,10-diphenyl-4-vinylidene-5-decine-3,8-diol (61 mg, 65%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.28-7.24(m, 4H), 7.18(d, J = 7.06 Hz, 6H), 5.17(s, 2H), 2.74-2.67(m, 4H), 2.60(s, 2H), 2.03-1.97(m, 2H), 1.90(ddd, J = 6.16, 7.2, 6.53 Hz, 2H), 1.44(s, 3H), 1.35(s, 3H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.28-7.24 (m, 4H), 7.18 (d, J = 7.06 Hz, 6H), 5.17 (s, 2H), 2.74-2.67 (m, 4H), 2.60 (s, 2H), 2.03-1.97 (m, 2H), 1.90 (ddd, J = 6.16, 7.2, 6.53 Hz, 2H), 1.44 (s, 3H), 1.35 (s, 3H)

제조예 20. 1,6-다이시클로헥실-2-비닐리덴-3-헥신-1,6-다이올의 제조Preparation Example 20 Preparation of 1,6-dicyclohexyl-2-vinylidene-3-hexine-1,6-diol

Figure 112007089104014-pat00025
Figure 112007089104014-pat00025

질소분위기 하에서 인듐(189 mg, 1.65 mmol)을 THF(1 mL) 용매에 녹인 후 여 기에 1,6-다이브로모-2,4-헥사다이인(195 mg. 0.825 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 시클로헥산온(49 mg, 0.5 mmol)를 반응용매에 첨가하여 실온에서 7 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 1,6-다이시클로헥실-2-비닐리덴-3-헥신-1,6-다이올(50 mg, 73%)을 얻었다.Dissolve indium (189 mg, 1.65 mmol) in THF (1 mL) solvent under nitrogen atmosphere, and then add 1,6-dibromo-2,4-hexadiyne (195 mg. 0.825 mmol) to THF (1.5 mL). After dissolving in, stirred for 15 minutes at room temperature, cyclohexanone (49 mg, 0.5 mmol) was added to the reaction solvent and stirred for 7 hours at room temperature, 10% hydrochloric acid aqueous solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated aqueous NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and the residue was separated by column chromatography to obtain 1,6-dicyclohexyl-2-vinylidene-3-hexine-1,6-diol (50 mg, 73%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 5.09(s, 2H), 2.52(s, 2H), 1.74-1.60(m, 12H), 1.59-1.48(m, 4H), 1.28-1.26(m, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 5.09 (s, 2H), 2.52 (s, 2H), 1.74-1.60 (m, 12H), 1.59-1.48 (m, 4H), 1.28- 1.26 (m, 2 H)

제조예 21. 2,7-다이페닐-3-비닐리덴-4-옥틴-2,7-다이올의 제조Preparation Example 21 Preparation of 2,7-diphenyl-3-vinylidene-4-octin-2,7-diol

Figure 112007089104014-pat00026
Figure 112007089104014-pat00026

질소분위기 하에서 인듐(189 mg, 1.65 mmol)을 THF(1 mL) 용매에 녹인 후 여기에 1,6-다이브로모-2,4-헥사다이인(195 mg. 0.825 mmol)을 THF(1.5 mL)에 녹인 후 실온에서 15분간 교반시킨 후 아세토페논(60 mg, 0.5 mmol)을 반응용매에 첨가하여 실온에서 20 시간 교반시킨 후 10% 염산 수용액(3 mL)을 가해 반응을 종결 시켰다. 이 혼합물은 Et2O(20 mL×3)로 추출하고 물(20 mL)과 포화 NaCl 수용 액(20 mL)으로 씻어주었다. 추출한 유기층은 무수 MgSO4로 건조하고 여과하였다. 용매를 제거한 후 관 크로마토그래피로 분리하여 2,7-다이페닐-3-비닐리덴-4-옥틴-2,7-다이올(108 mg, 68%)을 얻었다.Dissolve indium (189 mg, 1.65 mmol) in THF (1 mL) solvent under nitrogen atmosphere, and add 1,6-dibromo-2,4-hexadiyne (195 mg. 0.825 mmol) to THF (1.5 mL). After dissolving in the solution, the mixture was stirred at room temperature for 15 minutes, and then acetophenone (60 mg, 0.5 mmol) was added to the reaction solvent, and the mixture was stirred at room temperature for 20 hours, and 10% aqueous hydrochloric acid solution (3 mL) was added to terminate the reaction. The mixture was extracted with Et 2 O (20 mL × 3) and washed with water (20 mL) and saturated NaCl solution (20 mL). The extracted organic layer was dried over anhydrous MgSO 4 and filtered. The solvent was removed and then separated by column chromatography to obtain 2,7-diphenyl-3-vinylidene-4-octin-2,7-diol (108 mg, 68%).

1H NMR(400 MHz, CDCl3, 25℃, TMS) δ 7.40-7.26(m, 10H), 5.17(s, 1H), 2.87-2.64(m, 2H), 1.90(s, 2H), 1.54(d, J = 10.4 Hz, 3H), 1.41(d, J = 12.5 Hz, 3H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.40-7.26 (m, 10H), 5.17 (s, 1H), 2.87-2.64 (m, 2H), 1.90 (s, 2H), 1.54 ( d, J = 10.4 Hz, 3H), 1.41 (d, J = 12.5 Hz, 3H)

[실시예] EXAMPLE

상기한 제조예로부토 합성한 알렌인-1,6-다이올 유도체를 출발물질로 사용하여, 분자내 고리화 반응을 수행하여 상기 화학식 1로 표시되는 퓨란 유도체를 합성한 대표적 예이다.Using the allene-1,6-diol derivative synthesized by the above preparation as a starting material, it is a representative example of synthesizing the furan derivative represented by the formula (1) by performing an intramolecular cyclization reaction.

실시예 1. 1-(5-프로필-4-비닐퓨란-2-일)-펜탄-2-올의 제조Example 1 Preparation of 1- (5-propyl-4-vinylfuran-2-yl) -pentan-2-ol

Figure 112007089104014-pat00027
Figure 112007089104014-pat00027

질소 분위기 하에서 실버 트리플레이트(AgOTf, 7.7 mg, 0.03 mmol)를 CH2Cl2(0.5 mL) 용매에 녹인 후 여기에 5-비닐리덴-6-도데신-4,9-다이올(44 mg, 0.2 mmol)를 CH2Cl2(1 mL) 용매에 녹여 실온에서 2.5시간 교반시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관 크로마토그래피로 분리하여 표제 화합물인 1-(5-프로필-4-비닐퓨란-2-일)-펜탄-2-올(30 mg, 68 %)을 얻었다.Silver triflate (AgOTf, 7.7 mg, 0.03 mmol) was dissolved in a CH 2 Cl 2 (0.5 mL) solvent under nitrogen atmosphere, and then 5-vinylidene-6-dodecine-4,9-diol (44 mg, 0.2 mmol) was dissolved in CH 2 Cl 2 (1 mL) solvent, stirred at room temperature for 2.5 hours, and the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 1- (5-propyl-4-vinylfuran-2-yl) -pentan-2-ol (30 mg, 68%).

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 6.50(dd, J = 17.4, 10.9 Hz, 1H), 6.21(s, 1H), 5.32(d, J = 17.4 Hz, 1H), 5.05(d, J = 10.9 Hz, 1H), 3.91-3.84(m, 1H), 2.78(dd, J = 4.02, 4.02 Hz, 1H), 2.65(dd, J = 7.92, 7.92 Hz, 1H), 2.59(t, J = 7.3Hz, 2H), 1.80(d, J = 4.02, 1H), 1.68-1.60(m, 2H), 1.55-1.36(m, 4H), 0.92(t, J = 7.49 Hz, 6H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 6.50 (dd, J = 17.4, 10.9 Hz, 1H), 6.21 (s, 1H), 5.32 (d, J = 17.4 Hz, 1H), 5.05 (d, J = 10.9 Hz, 1H), 3.91-3.84 (m, 1H), 2.78 (dd, J = 4.02, 4.02 Hz, 1H), 2.65 (dd, J = 7.92, 7.92 Hz, 1H), 2.59 ( t, J = 7.3 Hz, 2H), 1.80 (d, J = 4.02, 1H), 1.68-1.60 (m, 2H), 1.55-1.36 (m, 4H), 0.92 (t, J = 7.49 Hz, 6H)

실시예 2. 1-시클로헥실-2-(5-시클로헥실-4-비닐퓨란-2-일)-에탄올의 제조Example 2. Preparation of 1-cyclohexyl-2- (5-cyclohexyl-4-vinylfuran-2-yl) -ethanol

Figure 112007089104014-pat00028
Figure 112007089104014-pat00028

질소 분위기 하에서 실버 트리플레이트(7.7 mg, 0.03 mmol)를 CH2Cl2(0.5 mL) 용매에 녹인 후 여기에 1,6-다이사이클로헥실-2-비닐리덴-3-헥신-1,6-다이올(60 mg, 0.2 mmol)를 CH2Cl2(1 mL) 용매에 녹여 실온에서 1.5시간 교반시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관 크로마토그래피로 분리하여 표제 화합물인 1-시클로헥실-2-(5-시클로헥실-4-비닐퓨란-2-일)-에탄올(52 mg, 86 %)을 얻었다.Dissolve silver triflate (7.7 mg, 0.03 mmol) in CH 2 Cl 2 (0.5 mL) solvent under nitrogen atmosphere and add 1,6-dicyclohexyl-2-vinylidene-3-hexine-1,6-di All (60 mg, 0.2 mmol) was dissolved in CH 2 Cl 2 (1 mL) solvent, stirred at room temperature for 1.5 hours, and then the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 1-cyclohexyl-2- (5-cyclohexyl-4- vinylfuran-2-yl)-ethanol (52 mg, 86%).

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 6.49(dd, J = 17.4, 10.8 Hz, 1H), 6.14(s, 1H), 5.24(d, J = 17.4 Hz, 1H), 4.96(d, J = 10.8 Hz, 1H), 3.57-3.52(m, 1H), 2.76-2.54(m, 3H), 1.81-1.30(m, 13H), 1.29-1.10(m, 10H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 6.49 (dd, J = 17.4, 10.8 Hz, 1H), 6.14 (s, 1H), 5.24 (d, J = 17.4 Hz, 1H), 4.96 (d, J = 10.8 Hz, 1H), 3.57-3.52 (m, 1H), 2.76-2.54 (m, 3H), 1.81-1.30 (m, 13H), 1.29-1.10 (m, 10H)

실시예 3. 1-페닐-2-(5-페닐-4-비닐퓨란-2-일)-에탄올의 제조Example 3. Preparation of 1-phenyl-2- (5-phenyl-4-vinylfuran-2-yl) -ethanol

Figure 112007089104014-pat00029
Figure 112007089104014-pat00029

질소 분위기 하에서 실버 트리플레이트(7.7 mg, 0.03 mmol)를 CH2Cl2(0.5 mL) 용매에 녹인 후 여기에 1,6-다이페닐-2-비닐리덴-3-헥신-1,6-다이올(58 mg, 0.2 mmol)를 CH2Cl2(1 mL) 용매에 녹여 실온에서 1.5시간 교반시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관 크로마토그래피로 분리하여 표제 화합물인 1-페닐-2-(5-페닐-4-비닐퓨란-2-일)-에탄올(46 mg, 80 %)을 얻었다.Dissolve silver triflate (7.7 mg, 0.03 mmol) in CH 2 Cl 2 (0.5 mL) solvent under nitrogen atmosphere and add 1,6-diphenyl-2-vinylidene-3-hexine-1,6-diol (58 mg, 0.2 mmol) was dissolved in CH 2 Cl 2 (1 mL) solvent, stirred at room temperature for 1.5 hours, and the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 1-phenyl-2- (5-phenyl-4-vinylfuran-2-yl) -ethanol (46 mg, 80%).

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 7.55(d, J = 8.58 Hz, 2H), 7.43-7.34(m, 6H), 7.32-7.27(m, 2H), 6.84(dd, J = 17.3, 10.8 Hz, 1H), 6.39(s, 1H), 5.50(d, J = 17.3 Hz, 1H), 5.20(d, J = 10.8 Hz, 1H), 5.05(t, J = 6.5 Hz, 1H), 3.07(d, J = 6.5 Hz, 2H), 2.29(s, 1H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.55 (d, J = 8.58 Hz, 2H), 7.43-7.34 (m, 6H), 7.32-7.27 (m, 2H), 6.84 (dd, J = 17.3, 10.8 Hz, 1H), 6.39 (s, 1H), 5.50 (d, J = 17.3 Hz, 1H), 5.20 (d, J = 10.8 Hz, 1H), 5.05 (t, J = 6.5 Hz, 1H), 3.07 (d, J = 6.5 Hz, 2H), 2.29 (s, 1H)

실시예 4. 1-(4-클로로페닐)-2-[5-(4-클로로페닐)-4-비닐퓨란-2-일]-에탄올의 제조Example 4. Preparation of 1- (4-chlorophenyl) -2- [5- (4-chlorophenyl) -4-vinylfuran-2-yl] -ethanol

Figure 112007089104014-pat00030
Figure 112007089104014-pat00030

질소 분위기 하에서 실버 트리플레이트(7.7 mg, 0.03 mmol)를 CH2Cl2(0.5 mL) 용매에 녹인 후 여기에 1,6-비스-(4-클로로페닐)-2-비닐리덴-3-헥신-1,6-다이올(72 mg, 0.2 mmol)를 CH2Cl2(1 mL) 용매에 녹여 실온에서 3시간 교반시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관 크로마토그래피로 분리하여 표제 1-(4-클로로페닐)-2-[5-(4-클로로페닐)-4-비닐퓨란-2-일]-에탄올(57 mg, 79 %)을 얻었다.Dissolve silver triflate (7.7 mg, 0.03 mmol) in CH 2 Cl 2 (0.5 mL) solvent under nitrogen atmosphere and add 1,6-bis- (4-chlorophenyl) -2-vinylidene-3-hexyne-. 1,6-diol (72 mg, 0.2 mmol) was dissolved in CH 2 Cl 2 (1 mL) solvent, stirred at room temperature for 3 hours, and the reaction was terminated. The solvent of the reaction was removed and then separated by column chromatography to give the title 1- (4-chlorophenyl) -2- [5- (4-chlorophenyl) -4-vinylfuran-2-yl] -ethanol (57 mg, 79 %) Was obtained.

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 7.45(d, J = 8.59 Hz, 2H), 7.38(d, J = 8.59 Hz, 2H), 7.33(s, 4H), 6.77(dd, J = 17.4, 10.8 Hz, 1H), 6.38(s, 1H), 5.52(d, J = 17.3 Hz, 1H), 5.24(d, J = 10.8 Hz, 1H), 5.02(t, J = 6.51 Hz, 1H), 3.04(d, J = 6.51 Hz, 2H), 2.25(s, 1H) 1 H NMR (400 MHz, CDCl 3, 25 ° C, TMS) δ 7.45 (d, J = 8.59 Hz, 2H), 7.38 (d, J = 8.59 Hz, 2H), 7.33 (s, 4H), 6.77 (dd) , J = 17.4, 10.8 Hz, 1H), 6.38 (s, 1H), 5.52 (d, J = 17.3 Hz, 1H), 5.24 (d, J = 10.8 Hz, 1H), 5.02 (t, J = 6.51 Hz , 1H), 3.04 (d, J = 6.51 Hz, 2H), 2.25 (s, 1H)

실시예 5. 1-(3-메톡시페닐)-2-[5-(3-메톡시페닐)-4-비닐퓨란-2-일]-에탄올의 제조Example 5. Preparation of 1- (3-methoxyphenyl) -2- [5- (3-methoxyphenyl) -4-vinylfuran-2-yl] -ethanol

Figure 112007089104014-pat00031
Figure 112007089104014-pat00031

질소 분위기 하에서 실버 트리플레이트(7.7 mg, 0.03 mmol)를 CH2Cl2(0.5 mL) 용매에 녹인 후 여기에 1,6-비스-(3-메톡시페닐)-2-비닐리덴-3-헥신-1,6-다이올(70 mg, 0.2 mmol)를 CH2Cl2(1 mL) 용매에 녹여 실온에서 5시간 교반시킨 후 반응 을 종결시켰다. 반응물의 용매를 제거한 후 관 크로마토그래피로 분리하여 표제 화합물인 1-(3-메톡시페닐)-2-[5-(3-메톡시페닐)-4-비닐퓨란-2-일]-에탄올(57 mg, 81%)을 얻었다.Dissolve silver triflate (7.7 mg, 0.03 mmol) in CH 2 Cl 2 (0.5 mL) solvent under nitrogen atmosphere and add 1,6-bis- (3-methoxyphenyl) -2-vinylidene-3-hexyne -1,6-diol (70 mg, 0.2 mmol) was dissolved in a solvent of CH 2 Cl 2 (1 mL), stirred at room temperature for 5 hours, and the reaction was terminated. The solvent of the reaction product was removed and then separated by column chromatography to obtain the title compound 1- (3-methoxyphenyl) -2- [5- (3-methoxyphenyl) -4-vinylfuran-2-yl] -ethanol ( 57 mg, 81%).

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 7.35(m, 1H), 7.16(d, J = 7.83 Hz, 1H), 7.10-7.09(m, 1H), 6.99-6.97(m, 2H), 6.89-6.82(m, 4H), 6.41(s, 1H), 5.51(d, J = 17.4 Hz, 1H), 5.21(d, J = 10.8 Hz, 1H), 5.04(t, J = 6.5 Hz, 1H), 3.85(s, 3H), 3.81(s, 3H), 3.39(s, 1H), 3.08(d, J = 6.5 Hz, 2H) 1 H NMR (400 MHz, CDCl 3, 25 ° C., TMS) δ 7.35 (m, 1H), 7.16 (d, J = 7.83 Hz, 1H), 7.10-7.09 (m, 1H), 6.99-6.97 (m, 2H), 6.89-6.82 (m, 4H), 6.41 (s, 1H), 5.51 (d, J = 17.4 Hz, 1H), 5.21 (d, J = 10.8 Hz, 1H), 5.04 (t, J = 6.5 Hz, 1H), 3.85 (s, 3H), 3.81 (s, 3H), 3.39 (s, 1H), 3.08 (d, J = 6.5 Hz, 2H)

실시예 6. 1-(4-아세틸페닐)-2-[5-(4-아세틸페닐)-4-비닐퓨란-2-일]-에탄올의 제조Example 6. Preparation of 1- (4-acetylphenyl) -2- [5- (4-acetylphenyl) -4-vinylfuran-2-yl] -ethanol

Figure 112007089104014-pat00032
Figure 112007089104014-pat00032

질소 분위기 하에서 실버 트리플레이트(7.7 mg, 0.03 mmol)를 CH2Cl2(0.5 mL) 용매에 녹인 후 여기에 1,6-비스-(4-아세틸페닐)-2-비닐리덴-3-헥신-1,6-다이올(75 mg, 0.2 mmol)를 CH2Cl2(1 mL) 용매에 녹여 실온에서 4.5시간 교반시킨 후 반응을 종결시켰다. 반응물의 용매를 제거한 후 관 크로마토그래피로 분리하여 표제 화합물인 1-(4-아세틸페닐)-2-[5-(4-아세틸페닐)-4-비닐퓨란-2-일]-에탄올(64 mg, 85 %)을 얻었다.Dissolve silver triflate (7.7 mg, 0.03 mmol) in CH 2 Cl 2 (0.5 mL) solvent under nitrogen atmosphere and add 1,6-bis- (4-acetylphenyl) -2-vinylidene-3-hexyne-. 1,6-diol (75 mg, 0.2 mmol) was dissolved in a solvent of CH 2 Cl 2 (1 mL), stirred at room temperature for 4.5 hours, and the reaction was terminated. After removing the solvent of the reaction product was separated by column chromatography to give the title compound 1- (4-acetylphenyl) -2- [5- (4-acetylphenyl) -4-vinylfuran-2-yl] -ethanol (64 mg) , 85%).

1H NMR(400 MHz, CDCl3, 25 ℃, TMS) δ 7.96(dd, J = 7.02, 7.02 Hz, 4H), 7.63(d, J = 8.37 Hz, 2H), 7.51(d, J = 8.25 Hz, 2H), 6.86(dd, J = 17.3, 10.8 Hz, 1H), 6.43(s, 1H), 5.57(d, J = 17.3 Hz, 1H), 5.30(d, J = 10.8 Hz, 1H), 5.16(t, J = 6.48 Hz, 1H), 3.11(d, J = 6.48 Hz, 1H) 2.61(s, 3H), 2.60(s, 3H), 1.90(s, 1H) 1 H NMR (400 MHz, CDCl 3, 25 ° C, TMS) δ 7.96 (dd, J = 7.02, 7.02 Hz, 4H), 7.63 (d, J = 8.37 Hz, 2H), 7.51 (d, J = 8.25 Hz , 2H), 6.86 (dd, J = 17.3, 10.8 Hz, 1H), 6.43 (s, 1H), 5.57 (d, J = 17.3 Hz, 1H), 5.30 (d, J = 10.8 Hz, 1H), 5.16 (t, J = 6.48 Hz, 1H), 3.11 (d, J = 6.48 Hz, 1H) 2.61 (s, 3H), 2.60 (s, 3H), 1.90 (s, 1H)

이상에서 설명한 바와 같이, 본 발명에 따른 상기 화학식 1로 표시되는 퓨란 유도체는 신규 화합물이며, 은(Ag) 촉매 조건에서 알렌인-1,6-다이올 화합물의 분자내 고리화 반응으로 인한 산소-탄소 결합방법을 통해 높은 수율로 얻을 수 있다.As described above, the furan derivative represented by Chemical Formula 1 according to the present invention is a novel compound, and the oxygen- caused by intramolecular cyclization reaction of allene-in-1,6-diol compound under silver (Ag) catalyst condition. It can be obtained in high yield through the carbon bonding method.

또한 이렇게 제조된 본 발명의 퓨란 유도체는 천연물의 기본골격을 이루며 의약 또는 향수 등의 합성에 있어 중간체로서 유용하다.In addition, the furan derivatives of the present invention thus prepared are useful as intermediates in the synthesis of medicaments or perfumes, which form a basic skeleton of natural products.

Claims (7)

하기 화학식 1로 표시되는 퓨란 유도체 :Furan derivative represented by the following formula (1): [화학식 1][Formula 1]
Figure 112009064553141-pat00038
Figure 112009064553141-pat00038
상기 화학식 1에서, A 및 B는 각각 수소원자; C1-C6 알킬기; C5-C8 사이클로알킬기; 할로겐, C1-C6 알킬, C1-C6 알콕시, 및 C2-C6 알킬카보닐 중에서 선택된 치환체가 치환 또는 비치환된 페닐기를 나타내며; 다만 A와 B가 동시에 수소원자인 화합물은 제외한다.In Formula 1, A and B are each a hydrogen atom; C 1 -C 6 alkyl group; C 5 -C 8 cycloalkyl group; A substituent selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, and C 2 -C 6 alkylcarbonyl represents a substituted or unsubstituted phenyl group; Except for compounds in which A and B are hydrogen atoms at the same time.
제 1 항에 있어서,The method of claim 1, 상기 A 및 B가 각각 수소원자; C1-C4 알킬기; C5-C7 사이클로알킬기; 페닐기; 또는 할로겐, C1-C4 알킬, C1-C4 알콕시, 및 C2-C4 알킬카보닐 중에서 선택된 치환체가 치환된 페닐기이며; 다만 A와 B가 동시에 수소원자인 화합물은 제외하는 것을 특징으로 하는 화합물.A and B are each hydrogen atoms; C 1 -C 4 alkyl group; C 5 -C 7 cycloalkyl group; Phenyl group; Or a substituent selected from halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, and C 2 -C 4 alkylcarbonyl is a substituted phenyl group; However, the compound characterized in that A and B at the same time excludes a compound having a hydrogen atom. 제 2 항에 있어서,The method of claim 2, 상기 A 및 B가 각각 수소원자; 메틸기; 에틸기; n-프로필기; 이소프로필기; 부틸기; 이소부틸기; 헥실기; 사이클로헥실기; 페닐기; 또는 클로로, 요오도, 브로모, 메틸, 에틸, n-프로필, 이소프로필, 부틸, 메톡시, 에톡시, 프로폭시, 부톡시, 및 아세틸 중에서 선택된 치환체가 치환된 페닐기를 나타내고; 다만 A와 B가 동시에 수소원자인 화합물은 제외하는 것을 특징으로 하는 화합물.A and B are each hydrogen atoms; Methyl group; Ethyl group; n-propyl group; Isopropyl group; Butyl group; Isobutyl group; Hexyl group; Cyclohexyl group; Phenyl group; Or a phenyl group substituted with a substituent selected from chloro, iodo, bromo, methyl, ethyl, n-propyl, isopropyl, butyl, methoxy, ethoxy, propoxy, butoxy, and acetyl; However, the compound characterized in that A and B at the same time excludes a compound that is a hydrogen atom. 제 1 항에 있어서,The method of claim 1, 1-(5-프로필-4-비닐퓨란-2-일)-펜탄-2-올, 1- (5-propyl-4-vinylfuran-2-yl) -pentan-2-ol, 1-시클로헥실-2-(5-시클로헥실-4-비닐퓨란-2-일)-에탄올, 1-cyclohexyl-2- (5-cyclohexyl-4-vinylfuran-2-yl) -ethanol, 1-페닐-2-(5-페닐-4-비닐퓨란-2-일)-에탄올, 1-phenyl-2- (5-phenyl-4-vinylfuran-2-yl) -ethanol, 1-(4-클로로페닐)-2-[5-(4-클로로페닐)-4-비닐퓨란-2-일]-에탄올, 1- (4-chlorophenyl) -2- [5- (4-chlorophenyl) -4-vinylfuran-2-yl] -ethanol, 1-(3-메톡시페닐)-2-[5-(3-메톡시페닐)-4-비닐퓨란-2-일]-에탄올, 및1- (3-methoxyphenyl) -2- [5- (3-methoxyphenyl) -4-vinylfuran-2-yl] -ethanol, and 1-(4-아세틸페닐)-2-[5-(4-아세틸페닐)-4-비닐퓨란-2-일]-에탄올 중에서 선택된 것을 특징으로 하는 화합물.1- (4-acetylphenyl) -2- [5- (4-acetylphenyl) -4-vinylfuran-2-yl] -ethanol. 하기 화학식 2로 표시되는 알렌인-1,6-다이올 유도체를 AgOTf, AgBF4, AgSbF6, 및 AgAsF6로 이루어진 Ag+ 이온 함유 화합물으로부터 선택된 은(Ag) 촉매가 존재하는 조건에서 분자내 고리화 반응을 수행하여 하기 화학식 1로 표시되는 퓨란 유도체를 제조하는 방법 : An allene-1,6-diol derivative represented by the following formula (2) is an intramolecular ring in the presence of a silver (Ag) catalyst selected from Ag + ion-containing compounds consisting of AgOTf, AgBF 4 , AgSbF 6 , and AgAsF 6 Method of preparing a furan derivative represented by the following Chemical Formula 1 by carrying out a reaction: [화학식 2][Formula 2]
Figure 112009064553141-pat00034
Figure 112009064553141-pat00034
[화학식 1][Formula 1]
Figure 112009064553141-pat00039
Figure 112009064553141-pat00039
상기 화학식 1 또는 2에서, A 및 B는 각각 수소원자; C1-C6 알킬기; C5-C8 사이클로알킬기; 할로겐, 니트로, C1-C6 알킬, C1-C6 알콕시, C2-C6 알킬카보닐, C2-C6 알콕시카보닐 및 C2-C6 알카노에이트 중에서 선택된 치환체가 치환 또는 비치환된 페닐기; 페닐-C1-C6 알킬렌기; 또는 산소원자를 포함한 5 내지 8각형 헤테로싸이클기를 나타낸다.In Formula 1 or 2, A and B are each a hydrogen atom; C 1 -C 6 alkyl group; C 5 -C 8 cycloalkyl group; A substituent selected from halogen, nitro, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 2 -C 6 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl and C 2 -C 6 alkanoate is substituted or Unsubstituted phenyl group; Phenyl-C 1 -C 6 alkylene group; Or a 5 to 8 pentagonal heterocycle group containing an oxygen atom.
삭제delete 제 5 항에 있어서, 상기 은(Ag) 촉매는 상기 화학식 2로 표시되는 알렌인-1,6-다이올 유도체에 대하여 0.01 내지 0.5 당량 범위로 사용하는 것을 특징으로 하는 제조방법.The method according to claim 5, wherein the silver (Ag) catalyst is used in an amount of 0.01 to 0.5 equivalents based on the allene-1,6-diol derivative represented by Chemical Formula 2.
KR1020070128539A 2007-12-11 2007-12-11 Furan derivatives, and process for preparing them using Ag catalyst KR100941174B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070128539A KR100941174B1 (en) 2007-12-11 2007-12-11 Furan derivatives, and process for preparing them using Ag catalyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070128539A KR100941174B1 (en) 2007-12-11 2007-12-11 Furan derivatives, and process for preparing them using Ag catalyst

Publications (2)

Publication Number Publication Date
KR20090061511A KR20090061511A (en) 2009-06-16
KR100941174B1 true KR100941174B1 (en) 2010-02-10

Family

ID=40990968

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070128539A KR100941174B1 (en) 2007-12-11 2007-12-11 Furan derivatives, and process for preparing them using Ag catalyst

Country Status (1)

Country Link
KR (1) KR100941174B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6207336B2 (en) * 2012-11-12 2017-10-04 日本ポリプロ株式会社 Diol compound, catalyst for olefin polymerization, and method for producing olefin polymer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of organic chemistry, 1984, 49권, 3762면
Tetrahedron, 1987, 43권, 3309면

Also Published As

Publication number Publication date
KR20090061511A (en) 2009-06-16

Similar Documents

Publication Publication Date Title
JP2579677B2 (en) Isoquinoline derivatives
CA2531167C (en) Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
KR100941174B1 (en) Furan derivatives, and process for preparing them using Ag catalyst
EP2687521B1 (en) "Process for the enantioselective synthesis of landiolol"
CN101560191A (en) Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
KR100941173B1 (en) Dihydrofuran derivatives, and process for preparing them using Au catalyst
EP1731509B1 (en) Process for producing nitrogenous 5-membered cyclic compound
JP5574320B2 (en) Process for producing bisimidazolidine ligand and catalyst using the same.
KR100841407B1 (en) Allenyn-1,6-diol derivatives, and process for preparing them
KR100906478B1 (en) Homoallenyl alcohols and synthesis of them using indium
JP2007291010A (en) Method for producing optically active 2-methylepihalohydrin or the like
JPH0572906B2 (en)
KR101140134B1 (en) Novel 3-arylbutenolide derivatives and its preparation method
JP5232989B2 (en) Optically active 2,6-bisaminomethylpyridine derivative, production method thereof and use thereof
JP2012184229A (en) Process for enantioselective synthesis of landiolol
Roman Selected Michael additions to thiophene-containing analogues of chalcone
CN115504946B (en) Method for synthesizing alpha-ketoamide compound
KR102207534B1 (en) fabrication method of 3,4-Dihydropyranones and the 3,4-Dihydropyranones
CN109942480B (en) Synthetic method of aromatic ring indole-5-alcohol compound
KR102622992B1 (en) Method for preparing imidazoline derivatives and intermediates thereof
CA2782701A1 (en) Combretastatin derivative preparation method
JP7128629B2 (en) Method for producing lubiprostone
JPS5840939B2 (en) Method for producing cyclohexanedione derivatives
KR100941736B1 (en) Dihydrofuran derivatives and synthesis of them using gold-catalyst
CN116178336A (en) Method for synthesizing N-aryl ketimine by acid catalytic ketal method and application

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130111

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20131001

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee